Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial.
Background: This trial aimed to evaluate the anti-obesity effects and safety of Neoagaro-oligosaccharides (NAOs) in humans in a 16 week, randomized, double-blind, placebo-controlled clinical trial. Methods: One hundred overweight or obese subjects with a body mass index of 23 to 34.9 kg/m2 and a per...
| Publicado en: | BMC Complementary Medicine & Therapies Vol. 23; no. 1; pp. 1 - 14 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | diagnostic images research tables/charts randomized controlled trial Journal Article |
| Publicado: |
BioMed Central
10/19/2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |